[1]
N. del C. Galindo Sevilla and J. Mancilla Galindo, “Biopharmaceuticals at the Frontier of Medical Therapeutics: Monoclonal antibodies, RNAs and Gene editing”, HS, vol. 24, no. 3, pp. 638–646, Oct. 2025, doi: 10.19136/hs.a24n3.6109.